ARGENICA ORDINARY (AGN) Short Interest
ARGENICA ORDINARY (ASX:AGN) had 0.01% of shares reported as short positions as of 11 July 2026, representing 15,198 shares. ARGENICA ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Unlock advanced features: Custom dashboards, portfolio tracking, real-time alerts, and more
Argenica Therapeutics
Argenica Therapeutics Limited is a biotechnology company focused on developing novel neuroprotective treatments aimed at reducing brain damage following strokes and other severe brain injuries. Positioned as an innovator in the neuroprotection field, the company leverages cutting-edge research to create therapies that can potentially transform patient outcomes.